Last reviewed: May 30, 2026
Last updated: May 30, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
Mic B12 dosage typically ranges from 500 to 2,500 micrograms per injection, administered weekly or monthly depending on clinical indication and baseline B12 status. Optimal dosing requires baseline serum B12 and methylmalonic acid assessment to guide safe, evidence-based titration.
Understanding your baseline metabolic state matters more than following generic dosing schedules. PlexusDx supports a biomarker-informed approach: assess your current B12 status, metabolism, and genetic predispositions before starting, then partner with your provider to titrate intelligently based on objective markers and clinical response.
Baseline B12 Status and Dosage Selection
Serum B12 levels below 300 pg/mL typically warrant higher starting doses (1,000–1,500 mcg weekly), while levels 300–500 pg/mL may benefit from lower initiation (500–800 mcg). Methylmalonic acid and homocysteine levels provide functional B12 status even when serum B12 appears normal.
Your provider should assess intrinsic factor antibodies and parietal cell antibodies if pernicious anemia is suspected, as this autoimmune condition often requires more frequent dosing schedules. Dietary B12 intake, medication interactions (metformin, PPIs), and gastrointestinal health history all inform dosage selection.
Dosage Titration Protocols and Clinical Monitoring
Standard titration begins at 500–1,000 mcg weekly for 4–6 weeks, then reassesses serum B12 and functional markers. If symptoms persist and lab values remain suboptimal, dose may increase to 1,500–2,000 mcg weekly before transitioning to maintenance therapy.
Maintenance dosing typically ranges from 500 mcg monthly to 2,500 mcg every 3 months, depending on baseline deficiency severity and individual clearance rates. Repeat B12 and methylmalonic acid testing at 6–8 weeks post-initiation establishes whether the chosen dose achieves optimal metabolic correction.
| Baseline B12 Level |
Typical Starting Dose |
Titration Timeline |
Expected Response Assessment |
| <200 pg/mL |
1,000–1,500 mcg weekly |
4 weeks |
Serum B12 + MMA at week 4 |
| 200–300 pg/mL |
500–1,000 mcg weekly |
4–6 weeks |
Serum B12 + MMA at week 6 |
| 300–500 pg/mL |
500 mcg weekly |
6–8 weeks |
Serum B12 + MMA at week 8 |
| >500 pg/mL (maintenance) |
500–1,000 mcg monthly |
8–12 weeks |
Serum B12 annually or per symptoms |
Functional Markers Beyond Serum B12
Methylmalonic acid and homocysteine are functional B12 markers that may remain elevated even when serum B12 normalizes, signaling incomplete cellular repletion. Dosage adjustments based solely on serum B12 can miss persistent functional deficiency affecting energy metabolism and neurological function.
Holotranscobalamin (active B12) offers a more sensitive snapshot of circulating bioavailable B12 than standard serum assays. Providers using functional markers often titrate more precisely, avoiding both underdosing and unnecessary escalation, which improves outcomes and patient compliance.
Safety Considerations and Who Should Assess Dosage Eligibility
B12 injections are generally well-tolerated with minimal toxicity risk, as excess B12 is water-soluble and excreted. However, baseline kidney function, concurrent medications (metformin, H2 blockers, antibiotics), and autoimmune conditions require evaluation to confirm safe dosing and rule out contraindications.
Pregnancy, breastfeeding, and certain neurological conditions (subacute combined degeneration, peripheral neuropathy from B12 deficiency) may necessitate more aggressive dosing protocols. Your provider should assess these factors and any previous adverse reactions to injectable B12 before initiating or adjusting your personal dosage plan.
How PlexusDx Supports a More Personalized Approach
At PlexusDx, we recognize that optimal B12 dosing depends not just on current levels but on your metabolic foundation. While our Precision Peptide Genetic Test focuses on GLP-1 and peptide metabolism pathways, understanding your baseline metabolic state—including B12 status, homocysteine handling, and methylation capacity—may help provide context for personalized wellness strategies that your provider can tailor.
The Precision Peptide Genetic Test reveals predispositions in metabolic and nutrient-handling genes that may relate to energy production and metabolic efficiency. Specific variants affecting methylation, nutrient absorption, and mitochondrial function should be interpreted with your qualified healthcare provider to understand how they may inform your broader metabolic optimization strategy, including B12 dosing decisions.
If you are exploring peptide-based metabolic support (such as compounded GLP-1 or tirzepatide formulations), understanding your baseline B12 status and metabolic predispositions can support a more informed conversation with your provider about comprehensive metabolic health. Baseline biomarker assessment and genetic predisposition data work together to guide safe, individualized treatment protocols.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $179-$229/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
What is a typical starting dose of Mic B12?
Standard starting doses range from 500 to 1,500 micrograms weekly, depending on baseline serum B12 level and clinical indication. Your provider will assess your specific deficiency severity and recommend an appropriate initiation dose tailored to your metabolic needs.
How often should Mic B12 dosage be reassessed?
Most providers reassess after 4–6 weeks of therapy using serum B12 and functional markers like methylmalonic acid. Additional monitoring at 8–12 weeks confirms adequate repletion before transitioning to maintenance dosing, typically every 1–3 months.
Can genetic factors influence B12 metabolism and dosing needs?
Yes. Variants affecting methylation enzymes (MTHFR), transcobalamin binding, and homocysteine metabolism may influence B12 retention and utilization. The Precision Peptide Genetic Test can reveal predispositions in these metabolic pathways to support more personalized dosing conversations with your provider.
What are the side effects of Mic B12 injections?
Mic B12 is generally well-tolerated. Rare side effects include injection-site reactions, mild itching, or transient headache. Serious adverse events are uncommon. Always report any unexpected symptoms to your healthcare provider immediately.
How does PlexusDx support B12 dosing decisions?
PlexusDx emphasizes biomarker-guided protocols and offers the Precision Peptide Genetic Test to reveal metabolic predispositions relevant to nutrient handling. This information can help you and your provider optimize baseline health before pursuing compounded metabolic treatments like GLP-1 or tirzepatide.
Related Reading
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
NAD+ Price: Clinical Factors and Personalized Cost Considerations
Where To Buy Glutathione: Clinical Evidence and Provider-Guided Options